SMS Lifesciences Financials
NSE: SMSLIFE | BSE: 540679
₹1,462.50
As on 11-Sep-2026IST
Market cap
₹442 Cr
Revenue (TTM)
₹324 Cr
P/E Ratio
28
P/B Ratio
2.1
Div. Yield
0.1 %
Income Statement (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
324.23
|
344.72
|
305.96
|
315.56
|
350.07
|
265.59
|
|||||
|
Total Income
|
327.32
|
349.58
|
309.79
|
318.63
|
351.81
|
267.37
|
|||||
|
Total Expenditure
|
283.33
|
299.63
|
274.74
|
286.74
|
315.54
|
235.35
|
|||||
|
EBITDA
|
40.90
|
45.10
|
31.22
|
28.82
|
34.53
|
30.25
|
|||||
|
Depreciation
|
15.89
|
15.00
|
14.94
|
10.79
|
10.01
|
7.86
|
|||||
|
EBIT
|
25.01
|
30.10
|
16.28
|
18.04
|
24.53
|
22.39
|
|||||
|
Interest
|
6.48
|
8.77
|
10.26
|
6.87
|
6.23
|
4.60
|
|||||
|
Other Income
|
3.09
|
4.86
|
3.83
|
3.07
|
1.74
|
1.78
|
|||||
|
Exceptional Items
|
--
|
--
|
--
|
2.35
|
12.69
|
--
|
|||||
|
Profit before Tax
|
21.62
|
26.19
|
9.85
|
16.59
|
32.73
|
19.57
|
|||||
|
Provision for Tax
|
6.36
|
7.46
|
3.52
|
5.22
|
7.43
|
6.01
|
|||||
|
Profit after Tax
|
15.26
|
18.73
|
6.33
|
11.38
|
25.30
|
13.56
|
|||||
|
Minority Interest
|
0.54
|
1.38
|
2.77
|
0.09
|
0.02
|
--
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
15.80
|
20.11
|
9.09
|
11.46
|
25.32
|
13.56
|
Liabilities (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
213.55
|
196.56
|
176.81
|
168.61
|
152.23
|
129.22
|
|||||
|
Minority Interest
|
0.54
|
15.49
|
16.82
|
19.60
|
12.70
|
--
|
|||||
|
Non-Current Liabilities
|
68.58
|
35.88
|
52.32
|
73.11
|
56.38
|
59.00
|
|||||
|
Current Liabilities
|
156.28
|
151.07
|
148.81
|
137.06
|
143.06
|
118.76
|
|||||
|
Total Liabilities
|
454.41
|
398.99
|
394.77
|
398.39
|
364.37
|
306.98
|
Assets (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
277.03
|
239.42
|
235.25
|
235.77
|
200.73
|
176.01
|
|||||
|
Current Assets
|
163.11
|
159.57
|
159.52
|
162.62
|
163.64
|
130.97
|
|||||
|
Total Assets
|
454.41
|
398.99
|
394.77
|
398.39
|
364.37
|
306.98
|
|||||
|
Total Debt*
|
--
|
84.01
|
97.71
|
98.64
|
77.27
|
64.21
|
|||||
|
Net Current Assets
|
6.83
|
8.51
|
10.71
|
25.55
|
20.58
|
12.21
|
|||||
|
Contingent Liabilities
|
--
|
18.74
|
18.10
|
4.81
|
5.44
|
7.20
|
Cashflow (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
34.05
|
24.31
|
14.70
|
-11.24
|
35.17
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-15.00
|
-18.45
|
-31.29
|
-7.14
|
-26.23
|
|||||
|
Cash from Financing Activities
|
--
|
-19.12
|
-6.56
|
16.89
|
10.83
|
-2.55
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
-0.07
|
-0.71
|
0.29
|
-7.55
|
6.39
|
Financials Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
52.27
|
66.51
|
30.08
|
37.91
|
83.76
|
44.84
|
|||||
|
Cash EPS (₹)
|
52.27
|
111.56
|
70.34
|
73.32
|
116.78
|
70.84
|
|||||
|
Adjusted Book Value (₹)
|
712.43
|
650.15
|
584.84
|
557.71
|
503.53
|
427.40
|
|||||
|
Dividend per Share (₹)
|
0.10
|
1.50
|
1.50
|
1.50
|
1.50
|
1.50
|
|||||
|
Cash Flow per Share (₹)
|
--
|
112.64
|
80.39
|
48.61
|
-37.18
|
116.33
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
33.15
|
-12.00
|
-127.47
|
-176.86
|
-13.16
|
Profitability Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
12.60
|
7.42
|
9.45
|
18.42
|
12.96
|
|||||
|
ROE (%)
|
7.53
|
10.03
|
3.66
|
7.09
|
17.98
|
11.07
|
|||||
|
ROA (%)
|
3.61
|
4.72
|
1.60
|
2.98
|
7.54
|
4.82
|
|||||
|
EBIT Margin (%)
|
7.71
|
8.73
|
5.32
|
5.72
|
7.01
|
8.43
|
|||||
|
Net Margin (%)
|
4.66
|
5.36
|
2.04
|
3.57
|
7.19
|
5.07
|
|||||
|
Cash Profit Margin (%)
|
--
|
8.74
|
6.27
|
6.19
|
9.08
|
7.26
|
Growth Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-3.12
|
12.67
|
-3.04
|
-9.86
|
31.81
|
1.84
|
|||||
|
EBIT Growth (%)
|
-1.19
|
84.87
|
-9.72
|
-26.47
|
9.57
|
27.65
|
|||||
|
Net Profit Growth (%)
|
-8.47
|
196.03
|
-44.38
|
-55.03
|
86.62
|
33.13
|
|||||
|
EPS Growth (%)
|
-8.49
|
121.15
|
-20.68
|
-54.73
|
86.79
|
33.13
|
|||||
|
Book Value Growth (%)
|
--
|
11.17
|
4.86
|
10.76
|
17.81
|
11.65
|
Valuation Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
27.98
|
16.24
|
22.57
|
13.71
|
8.30
|
11.04
|
|||||
|
Price / Book Value
|
2.05
|
1.66
|
1.16
|
0.93
|
1.38
|
1.16
|
|||||
|
Dividend Yield (%)
|
0.10
|
0.14
|
0.22
|
0.29
|
0.22
|
0.30
|
|||||
|
EV/EBITDA
|
12.47
|
8.19
|
8.60
|
7.88
|
7.80
|
6.33
|
|||||
|
Close Price (₹)
|
1,455.60
|
1,078.00
|
676.15
|
510.05
|
699.25
|
491.85
|
|||||
|
High Price (₹)
|
1,778.35
|
1,749.65
|
707.05
|
948.65
|
1,024.90
|
749.90
|
|||||
|
Low Price (₹)
|
1,050.05
|
626.45
|
464.05
|
500.00
|
470.00
|
167.05
|
|||||
|
Market Cap (₹ Cr)
|
442.16
|
326.63
|
205.21
|
157.21
|
210.11
|
149.61
|
Solvency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.23
|
0.43
|
0.55
|
0.59
|
0.51
|
0.50
|
|||||
|
Short term debt to equity ratio
|
--
|
0.26
|
0.26
|
0.18
|
0.18
|
0.16
|
|||||
|
Current Ratio
|
1.04
|
1.06
|
1.07
|
1.19
|
1.14
|
1.10
|
|||||
|
Quick Ratio
|
0.53
|
0.61
|
0.53
|
0.56
|
0.55
|
0.58
|
|||||
|
Interest Coverage
|
4.34
|
3.99
|
1.96
|
3.42
|
6.26
|
5.26
|
Operating Efficiency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
18.92
|
19.95
|
16.78
|
14.60
|
9.66
|
12.86
|
|||||
|
Asset Turnover
|
0.77
|
0.97
|
0.85
|
0.94
|
1.16
|
1.05
|
|||||
|
Receivable days
|
--
|
56.81
|
52.44
|
40.71
|
31.92
|
34.48
|
|||||
|
Inventory Days
|
--
|
70.27
|
90.14
|
87.15
|
68.75
|
77.87
|
|||||
|
Payable days
|
--
|
133.15
|
143.42
|
146.47
|
135.85
|
154.56
|
|||||
|
Cash Conversion Cycle
|
--
|
-6.07
|
-0.85
|
-18.60
|
-35.18
|
-42.21
|